In vivo signaling through the neurokinin 1 receptor favors transgene expression by langerhans cells and promotes the generation of Th1- and Tc1-biased immune responses

Journal of Immunology

Volumn 178, Issue 11, 2007, Pages 7006-7017

  Mathers, Alicia R ^a   Tckacheva, Olga A ^a   Janelsinis, Brian M ^a   Shufesky, William J ^a,b   Morelli, Adrian E ^a,b   Larregina, Adriana T ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; NEUROPEPTIDE; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; CELL MIGRATION; CELL NUCLEUS; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; EFFECTOR CELL; EPIDERMIS; EPIDERMIS CELL; FEMALE; GENE DELIVERY SYSTEM; GENE GUN; GENETIC IMMUNIZATION; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; IN VIVO STUDY; INFLAMMATION; LANGERHANS CELL; MOUSE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TC1 CELL; TH1 CELL; TRANSGENE;

EID: 34249803831     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.11.7006     Document Type: Article

References (65)

1. + T cells: when, where, and how. Annu. Rev. Immunol. 24: 519-540.
2. Kirk, C. J., and J. J. Mule. 2000. Gene-modified dendritic cells for use in tumor vaccines. Hum. Gene Ther. 11: 797-806.
3. Melief, C. J., S. H. Van Der Burg, R. E. Toes, F. Ossendorp, and R. Offringa. 2002. Effective therapeutic anticancer vaccines based on precision guiding of cytolytic T lymphocytes. Immunol. Rev. 188: 177-182.
4. Dobrzanski, M. J., J. B. Reome, and R. W. Dutton. 2001. Immunopotentiating role of IFN-γ in early and late stages of type 1 CD8 effector cell-mediated tumor rejection. Clin. Immunol. 98: 70-84.
5. Helmich, B. K., and R. W. Dutton. 2001. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. J. Immunol. 166: 6500-6508.
6. Schirmbeck, R., and J. Reimann. 2001. Modulation of gene-gun-mediated Th2 immunity to hepatitis B surface antigen by bacterial CpG motifs or IL-12. Intervirology 44: 115-123.
7. Larregina, A. T., L. A. Spencer, and L. D. Falo, Jr. 2004. The skin as a target to modulate immune responses through genetic immunization. In Frontiers in Immuno-gene Therapy. O. Mazda, ed. Research Signpost, Trivandrum, pp. 59-77.
8. Larregina, A. T., and L. D. Falo, Jr. 2005. Changing paradigms in cutaneous immunology: adapting with dendritic cells. J. Invest. Dermatol. 124: 1-12.
9. + cells differentiate into Langerhans cells. Nat. Immunol. 2: 1151-1158.
10. Larregina, A. T., and L. D. Falo, Jr. 2001. Dendritic cells in the context of skin immunity. In Dendritic Cells: Biology and Clinical Applications, 2nd Ed. M. Lotze and A. W. Thomson, eds. Academic Press, New York, pp. 301-314.
11. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
12. Bos, J. 2005. Skin immune system (SIS). In Skin Immune System, 3rd Ed. J. Bos, ed. CRC Press, Boca Raton, pp. 3-11.
13. Hosoi, J., G. F. Murphy, C. L. Egan, E. A. Lerner, S. Grabbe, A. Asahina, and R. D. Granstein. 1993. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363: 159-163.
14. Egan, C. L., M. J. Viglione-Schneck, L. J. Walsh, B. Green, J. Q. Trojanowski, D. Whitaker-Menezes, and G. F. Murphy. 1998. Characterization of unmyelinated axons uniting epidermal and dermal immune cells in primate and murine skin. J. Cutan. Pathol. 25: 20-29.
15. O'Connor, T. M., J. O'Connell, D. I. O'Brien, T. Goode, C. P. Bredin, and F. Shanahan. 2004. The role of substance P in inflammatory disease. J. Cell. Physiol. 201: 167-180.
16. Morteau, O., B. Lu, C. Gerard, and N. P. Gerard. 2001. Hemokinin 1 is a full agonist at the substance P receptor. Nat. Immunol. 2: 1088.
17. Bellucci, F., F. Carini, C. Catalani, P. Cucchi, A. Lecci, S. Meini, R. Patacchini, L. Quartara, R. Ricci, M. Tramontana, et al. 2002. Pharmacological profile of the novel mammalian tachykinin, hemokinin 1. Br. J. Pharmacol. 135: 266-274.
18. Zhang, Y., L. Lu, C. Furlonger, G. E. Wo, and C. I. Paige. 2000. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1: 392-397.
19. Scholzen, T. E., M. Steinhoff, A. Sindrilaru, A. Schwarz, N. W. Bunnett, T. A. Luger, C. A. Armstrong, and J. C. Ansel. 2004. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin I receptors and augmented by neurokinin 2 receptor blockage. FASEB J. 18: 1007-1009.
20. Lambrecht, B. N., P. R. Germonpre, E. G. Everaert, I. Carro-Muino, M. De Veerman, C. de Felipe, S. P. Hunt, K. Thielemans, G. F. Joos, and R. A. Pauwels. 1999. Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR. ligation. Eur. J. Immunol. 29: 3815-3825.
21. Nio, D. A., R. N. Moylan, and J. K. Roche. 1993. Modulation of T lymphocyte function by neuropeptides: evidence for their role as local immunoregulatory elements. J. Immunol. 150: 5281-5288.
22. Lighvani, S., X. Huang, P. P. Trivedi, R. H. Swanborg, and L. D. Hazlett. 2005. Substance P regulates natural killer cell interferon γ production and resistance to Pseudomonas aeruginosa infection. Eur. J. Immunol. 35: 1567-1575.
23. Niizeki, H., I. Kurimoto, and J. W. Streilein. 1999. A substance P agonist acts as an adjuvant to promote hapten-specific skin immunity. J. Invest. Dermatol. 112: 437-442.
24. Larregina, A. T., S. C. Watkins, G. Erdos, L. A. Spencer, W. J. Storkus, D. Beer Stolz, and L. D. Falo, Jr. 2001. Direct transfection and activation of human cutaneous dendritic cells. Gene Ther. 8: 608-617.
25. Morel, P. A., D. Falkner, J. Plowey, A. T. Larregina, and L. D. Falo. 2004. DNA immunization: altering the cellular localization of expressed protein and the immunization route allows manipulation of the immune response. Vaccine 22: 447-456.
26. + T cells after gene gun immunization. J. Exp. Med. 188: 1075-1082.
27. Condon, C., S. C. Watkins, C. M. Celluzzi, K. Thompson, and L. D. Falo, Jr. 1996. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Med. 2: 1122-1128.
28. Alvarez, D., G. Harder, R. Fattouh, J. Sun, S. Goncharova, M. R. Stampfli, A. J. Coyle, J. L. Bramson, and M. Jordana. 2005. Cutaneous antigen priming via gene gun leads to skin-selective Th2 immune-inflammatory responses. J. Immunol. 174: 1664-1674.
29. Liu, L., X. Zhou, H. Liu, L. Xiang, and Z. Yuan. 2005. CpG motif acts as a "danger signal" and provides a T helper type 1-biased microenvironment for DNA vaccination. Immunology 115: 223-230.
30. Weiss, R., S. Scheiblhofer, J. Freund, F. Ferreira, I. Livey, and J. Thalhamer. 2002. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine 20: 3148-3154.
31. Feltquate, D. M., S. Heaney, R. G. Webster, and H. L. Robinson. 1997. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158: 2278-2284.
32. Kaplan, D. H., M. C. Jenison, S. Saeland, W. D. Shlomchik, and M. J. Shlomchik. 2005. Epidermal Langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-620.
33. Grabbe, S., K. Steinbrink, M. Steinert, T. A. Luger, and T. Schwarz. 1995. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J. Immunol. 155: 4207-4217.
34. Mizumoto, N., T. Kumamoto, S. C. Robson, J. Sevigny, H. Matsue, K. Enjyoji, and A. Takashima. 2002. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat. Med. 8: 358-365.
35. Nickoloff, B. J. 2002. Cutaneous dendritic cells in the crossfire between innate and adaptive immunity. J. Dermatol. Sci. 29: 159-165.
36. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhe, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
37. Zhao, X., E. Deak, K. Soderberg, M. Linehan, D. Spezzano, J. Zhu, D. M. Knipe, and A. Iwasaki. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162.
38. Ritter, U., A. Meissner, C. Scheidig, and H. Korner. 2004. CD8α- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur. J. Immunol. 34: 1542-1550.
39. Larregina, A. T., A. E. Morelli, O. Tkacheva, G. Erdos, C. Donahue, S. C. Watkins, A. W. Thomson, and L. D. Falo, Jr. 2004. Highly efficient expression of transgenic proteins by naked DNA-transfected dendritic cells through terminal differentiation. Blood 103: 811-819.
40. Hokey, D. A., A. T. Larregina, G. Erdos, S. C. Watkins, and L. D. Falo, Jr. 2005. Tumor cell loaded type 1 polarized dendritic cells induce Th1-mediated tumor immunity. Cancer Res. 65: 10059-10067.
41. + dendritic cells but not by Langerhans cells. Science 301: 1925-1928.
42. Belz, G. T., C. M. Smith, L. Kleinert, P. Reading, A. Brooks, K. Shortman, F. R. Carbone, and W. R. Heath. 2004. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 101: 8670-8675.
43. + dendritic cells are generally involved in priming CTL immunity to viruses. J. Immunol. 172: 1996-2000.
44. Barratt-Boyes, S. M., M. I. Zimmer, L. A. Harshyne, E. M. Meyer, S. C. Watkins, S. Capuano III, M. Murphey-Corb, L. D. Falo, Jr., and A. D. Donnenberg. 2000. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J. Immunol. 164: 2487-2495.
45. Sambucetti, L. C., J. M. Cherrington, G. W. Wilkinson, and E. S. Mocarski. 1989. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J. 8: 4251-4258.
46. Morelli, A. E., A. T. Larregina, R. W. Ganster, A. F. Zahorchak, J. M. Plowey, T. Takayama, A. J. Logar, P. D. Robbins, L. D. Falo, and A. W. Thomson. 2000. Recombinant adenovirus induces maturation of dendritic cells via an NF-κB-dependent pathway. J. Virol. 74: 9617-9628.
47. Barratt-Boyes, S. M., and C. G. Figdor. 2004. Current issues in delivering DCs for immunotherapy. Cytotherapy 6: 105-110.
48. Yang, Y., F. A. Nunes, K. Berencsi, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91: 4407-4411.
49. Yewdell, J. W., and A. B. Hill. 2002. Viral interference with antigen presentation. Nat. Immunol. 3: 1019-1025.
50. + T cell responses in gene gun DNA immunization. J. Immunol. 167: 5549-5557.
51. + T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 24: 643-656.
52. Toews, G. B., P. R. Bergstresser, and J. W. Streilein. 1980. Langerhans cells: sentinels of skin associated lymphoid tissue. J. Invest. Dermatol. 75: 78-82.
53. Streilein, J. W., G. T. Toews, J. N. Gilliam, and P. R. Bergstresser. 1980. Tolerance or hypersensitivity to 2,4-dinitro-1-fluorobenzene: the role of Langerhans cell density within epidermis. J. Invest. Dermatol. 74: 319-322.
54. Merad, M., P. Hoffmann, E. Ranheim, S. Slaymaker, M. G. Manz, S. A. Lira, I. Charo, D. N. Cook, I. L. Weissman, S. Strober, and E. G. Engleman. 2004. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10: 510-517.
55. Larsen, C. P., R. M. Steinman, M. Witmer-Pack, D. F. Hankins, P. J. Morris, and J. M. Austyn. 1990. Migration and maturation of Langerhans cells in skin transplants and explants. J. Exp. Med. 172: 1483-1493.
56. Nestle, F. O., X. G. Zheng, C. B. Thompson, L. A. Turka, and B. J. Nickoloff. 1993. Characterization of dermal dendritic cells obtained from normal human skin reveals phenotypic and functionally distinctive subsets. J. Immunol. 151: 6535-6545.
57. Crook, K., G. McLachlan, B. J. Stevenson, and D. J. Porteous. 1996. Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation. Gene Ther. 3: 834-839.
58. Suck, D., and C. Oefner. 1986. Structure of DNase I at 2.0 A resolution suggests a mechanism for binding to and cutting DNA. Nature 321: 620-625.
59. Khawaja, A. M., and D. F. Rogers. 1996. Tachykinins: receptor to effector. Int. J. Biochem. Cell Biol. 28: 721-738.
60. Weinstock, J. V. 2004. The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses. Front. Biosci. 9: 1936-1943.
61. Jarvikallio, A., I. T. Harvima, and A. Naukkarinen. 2003. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch. Dermatol. Res. 295: 2-7.
62. Luger, T. A. 2002. Neuromediators: a crucial component of the skin immune system. J. Dermatol. Sci. 30: 87-93.
63. Marriott, I., M. J. Mason, A. Elhofy, and K. L. Bost. 2000. Substance P activates NF-κB independent of elevations in intracellular calcium in murine macrophages and dendritic cells. J. Neuroimmunol. 102: 163-171.
64. Staniek, V., L. Misery, J. Peguet-Navarro, J. Abello, J. D. Doutremepuich, A. Claudy, and D. Schmitt. 1997. Binding and in vitro modulation of human epidermal Langerhans cell functions by substance P. Arch. Dermatol. Res. 289: 285-291.
65. Angeli, V., F. Ginhoux, J. Llodra, L. Quemeneur, P. S. Frenette, M. Skobe, R. Jessberger, M. Merad, and G. J. Randolph. 2006. B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization. Immunity 24: 203-215.